Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): An Eastern Cooperative Oncology Group study

M. D. Abeloff, D. M. Finkelstein, A. Y.C. Chang, F. J. Camacho, R. H. Creech, D. S. Ettinger

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): An Eastern Cooperative Oncology Group study'. Together they form a unique fingerprint.